KA
CL icon

Kovack Advisors’s Colgate-Palmolive CL Stock Holding History

Kovack Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$572K Buy
6,705
+227
+4% +$20.2K 0.03% 553
2025
Q4 		$512K Buy
6,478
+1,509
+30% +$118K 0.02% 586
2025
Q3 		$397K Buy
4,969
+175
+4% +$14.9K 0.04% 390
2025
Q2 		$436K Buy
4,794
+114
+2% +$10.4K 0.04% 373
2025
Q1 		$438K Buy
4,680
+27
+0.6% +$2.42K 0.05% 335
2024
Q4 		$423K Buy
4,653
+203
+5% +$19.4K 0.04% 351
2024
Q3 		$462K Buy
4,450
+202
+5% +$20.6K 0.05% 323
2024
Q2 		$412K Sell
4,248
-497
-10% -$45.8K 0.05% 348
2024
Q1 		$427K Buy
4,745
+865
+22% +$73.3K 0.05% 283
2023
Q4 		$309K Buy
3,880
+603
+18% +$45.3K 0.04% 409
2023
Q3 		$233K Buy
+3,277
New +$245K 0.03% 448
2018
Q4 		– Sell
-3,328
Closed -$223K – 432
2018
Q3 		$223K Buy
+3,328
New +$222K 0.06% 368

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Kovack Advisors's CL Position: Q1 2026 in Review

Kovack Advisors increased its Colgate-Palmolive (CL) stake by 3.5% in Q1 2026, buying an estimated $20.2K and bringing the position to 6,705 shares worth $572K. The position accounts for 0.03% of the portfolio, ranked #553.

Kovack Advisors first reported a position in CL in Q3 2018 and has held it in 12 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Kovack Advisors held 6,705 shares of Colgate-Palmolive worth $572K as of Q1 2026.
  • Kovack Advisors bought 227 Colgate-Palmolive shares in Q1 2026, an estimated $20.2K.
  • Colgate-Palmolive made up 0.03% of Kovack Advisors's portfolio in Q1 2026, its #553 holding.
  • Kovack Advisors first reported a position in Colgate-Palmolive in Q3 2018 and has held it in 12 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.